Metro

Cofounders of pharmacy blamed in deadly outbreak arrested

Tainted steroids manufactured by the New England Compounding Center were blamed for a 2012 outbreak.

AP/File 2012

Tainted steroids manufactured by the New England Compounding Center were blamed for a 2012 outbreak.

Two cofounders and 12 other former employees of a Massachusetts compounding pharmacy blamed for a fungal meningitis outbreak that killed 64 people were arrested early Wednesday, a spokeswoman for the US attorney’s office in Boston said.

Gregory Conigliaro and Barry Cadden, co-founders of the New England Compounding Center in Framingham, were among 14 people arrested at their homes around the state, attorney’s office spokeswoman Christina DiIorio-Sterling said.

Advertisement

One of those arrested was Glenn Adam Chin, a former supervisory pharmacist, who had been charged with mail fraud in September.

Tainted steroids manufactured by the pharmacy were blamed for a 2012 outbreak. About 750 people in 20 states developed meningitis or other infections after receiving the contaminated steroids. Michigan, Tennessee and Indiana were the hardest-hit states.

The exact charges are expected to be disclosed at a news conference later Wednesday, and all expected to make an initial court appearance later in the day.

The pharmacy gave up its license and filed for bankruptcy protection after it was flooded with hundreds of lawsuits filed by victims and their families.

NECC was founded in 1998 by brothers-in-law Cadden and Conigliaro. Cadden, who is married to Conigliaro’s sister, Lisa, earned a pharmacy degree from the University of Rhode Island. Conigliaro is an engineer.

Related coverage:

Advertisement

$135 million deal proposed in NECC bankruptcy case

Pharmacist tied to outbreak a ‘scapegoat,’ lawyer says

Canton man tied to tainted medicine arrested at Logan

New law increases oversight of compounding pharmacies

$100m settlement reached over meningitis cases

Pain, questions linger, a year after meningitis outbreak

Globe coverage of the outbreak

Loading comments...
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.